Publications
By Year
Now showing items 121-140 of 5153 records
Influence of angiotensin II on the gut microbiome: modest effects in comparison to experimental factors.
Rikeish R Muralitharan; Michael E Nakai; Matthew Snelson; Tenghao Zheng; Evany Dinakis; Liang Xie; Hamdi Jama; Madeleine Paterson; Waled Shihata; Flavia Wassef; Antony Vinh; Grant R Drummond; David M Kaye; Charles R Mackay; Francine Z Marques
CARDIOVASCULAR RESEARCH - 02 Sep 2024
Animal models are regularly used to test the role of the gut microbiome in hypertension. Small-scale pre-clinical studies have investigated changes to the gut microbiome in the angiotensin II hypertensive model. However, the gut microbiome is influenced by internal and external experimental factors, which are not regularly considered in the study design. Once these factors are accounted for, it...
Effort minimization: A permanent, dynamic, and surmountable influence on physical activity.
Silvio Maltagliati; Layan Fessler; Qian Yu; Zhihao Zhang; Yanxia Chen; Olivier Dupuy; Ryan S Falck; Neville Owen; Liye Zou; Boris Cheval
JOURNAL OF SPORT AND HEALTH SCIENCE - 02 Sep 2024
Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes.
Fanny Jansson Sigfrids; Raija Lithovius; Per-Henrik Groop; Lena M Thorn
DIABETIC MEDICINE : A JOURNAL OF THE BRITISH DIABETIC ASSOCIATION - 05 Sep 2024
Across its operational span of more than 25 years, the observational, nationwide, multicentre Finnish Diabetic Nephropathy (FinnDiane) Study has aimed to unravel mechanisms underlying diabetic kidney disease, with a special focus on its metabolic risk factors. We sought to compile key findings relating to this topic and to offer a current perspective on the natural course of diabetic kidney dis...
Life-period associations of body mass index with adult carotid intima-media thickness: The Bogalusa heart study and the cardiovascular risk in young Finns study.
Jack T Evans; Marie-Jeanne Buscot; Brooklyn J Fraser; Markus Juonala; Yajun Guo; Camilo Fernandez; Mika Kähönen; Matthew A Sabin; Matthew K Armstrong; Jorma S A Viikari; Lydia A Bazzano; Olli T Raitakari; Costan G Magnussen
PREVENTIVE MEDICINE - 05 Sep 2024
Child and adult body mass index (BMI) associates with adult carotid artery intima-media thickness (cIMT). However, the relative contribution of BMI at different life-periods on adult cIMT has not been quantified. This study aimed to determine the life-course model that best explains the relative contribution of BMI at different life-periods (childhood, adolescence, and young-adulthood) on cIMT ...
Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme.
Adrian D Elliott; Melissa E Middeldorp; Julie R McMullen; Diane Fatkin; Liza Thomas; Kylie Gwynne; Adam P Hill; Catherine Shang; Meng-Ping Hsu; Jamie I Vandenberg; Jonathan M Kalman; Prashanthan Sanders;
HEART, LUNG & CIRCULATION - 06 Sep 2024
Atrial fibrillation (AF) is highly prevalent in the Australian community, ranking amongst the highest globally. The consequences of AF are significant. Stroke, dementia and heart failure risk are increased substantially, hospitalisations are amongst the highest for all cardiovascular causes, and Australians living with AF suffer from substantial symptoms that impact quality of life. Australian ...
Strain surveillance during chemotherapy to improve cardiovascular outcomes: the SUCCOUR-MRI trial.
Thomas H Marwick; Elizabeth Dewar; Mark Nolan; Mitra Shirazi; Peter Dias; Leah Wright; Ben Fitzgerald; Leighton Kearney; Piyush Srivastava; John Atherton; Kazuaki Negishi; Aaron L Sverdlov; Sudhir Wahi; James Otton; Joseph Selvanayagam; Liza Thomas; Paaladinesh Thavendiranathan;
EUROPEAN HEART JOURNAL - 01 Sep 2024
The detection of cancer therapy-related cardiac dysfunction (CTRCD) by reduction of left ventricular ejection fraction (LVEF) during chemotherapy usually triggers the initiation of cardioprotective therapy. This study addressed whether the same approach should be applied to patients with worsening of global longitudinal strain (GLS) without attaining thresholds of LVEF. Strain sUrveillance duri...
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary Prevention
Jingqin Wu; Corey Giles; Aleksandar Dakic; Habtamu Beyene; Kevin Huynh; Tingting Wang; Thomas Meikle; Gavriel Olshansky; Agus Salim; Thy Duong; Gerald F Watts; Joseph Hung; Jennie Hui; Gemma Cadby; John Beilby; John Blangero; Eric Moses; Jonathan Shaw; Dianna Magliano; Dantong Zhu; Jean Yang; Stuart Grieve; Andrew Wilson; Clara Chow; Stephen Vernon; Michael Gray; Gemma Figtree; Melinda Carrington; Mike Inouye; Thomas Marwick; Peter Meikle
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY - 22 Jul 2024
Background Accurate risk stratification is vital for primary prevention of cardiovascular disease (CVD). However, traditional tools such as the Framingham Risk Score (FRS) may underperform within the diverse intermediate-risk group, which includes individuals requiring distinct management strategies. Objectives This study aimed to develop a lipidomic-enhanced risk score (LRS), specifically tar...
GLUT1 and cerebral glucose hypometabolism in human focal cortical dysplasia is associated with hypermethylation of key glucose regulatory genes.
Chaitali Ghosh; Rosemary Westcott; David Skvasik; Ishant Khurana; Jean Khoury; Ingmar Blumcke; Assam El-Osta; Imad M Najm
RESEARCH SQUARE - 17 Oct 2024
Focal cortical dysplasia (FCD) is recognized as a significant etiological factor in pharmacoresistant intractable epilepsy, linked with disturbances in neurovascular metabolism. Our study investigated regulation of glucose-transporter1 (GLUT1) and cerebral hypometabolism within FCD subtypes. Surgically excised human brain specimens underwent histopathological categorization. A subset of samples...
General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants.
Jonathan Shaw; NCD Risk Factor Collaboration (NCD-RisC); Dianna Magliano
LANCET (LONDON, ENGLAND) - 31 Aug 2024
Adiposity can be measured using BMI (which is based on weight and height) as well as indices of abdominal adiposity. We examined the association between BMI and waist-to-height ratio (WHtR) within and across populations of different world regions and quantified how well these two metrics discriminate between people with and without hypertension. We used data from studies carried out from 1990 t...
Diagnosis to Ablation in Persistent AF: Any Time Can Be a Good Time to Ablate.
Rose Crowley; Michael W Lim; David Chieng; Louise Segan; Jeremy William; Joseph B Morton; Geoffrey Lee; Paul Sparks; Alex J McLellan; Hariharan Sugumar; Sandeep Prabhu; Liang-Han Ling; Aleksandr Voskoboinik; Rajeev K Pathak; Laurence Sterns; Matthew Ginks; Prashanthan Sanders; Peter M Kistler; Jonathan M Kalman
JACC. CLINICAL ELECTROPHYSIOLOGY - 01 Jul 2024
Nonrandomized data suggest that longer diagnosis-to-ablation time (DAT) is associated with poorer outcomes; however, a recent randomized trial found no difference in recurrences when ablation was delayed by 12 months. This study sought to assess the impact of DAT on atrial fibrillation (AF) recurrence in patients undergoing catheter ablation for persistent AF. CAPLA (Effect of Catheter Ablation...
Predictors of Late Atrial Fibrillation Recurrence After Cardiac Surgery.
Jeremy William; Kate Rowe; Joseph Hogarty; Xiaoman Xiao; Anita Shirwaiker; Jason E Bloom; Silvana Marasco; Adam Zimmet; Christopher Merry; Justin Negri; Atsuo Doi; Julian Gooi; David McGiffin; Jonathan M Kalman; Sandeep Prabhu; Peter M Kistler; Aleksandr Voskoboinik
JACC. CLINICAL ELECTROPHYSIOLOGY - 01 Jul 2024
Although postoperative atrial fibrillation (POAF) frequently occurs early after cardiac surgery, there is a paucity of data evaluating predictors and timing of late atrial fibrillation (AF) recurrence. The authors sought to evaluate predictors of late AF recurrence in patients undergoing cardiac surgery. We retrospectively reviewed cardiac surgery patients from 2010 to 2018 with no preoperative...
Cancer Therapy and Exercise Intolerance: The Heart Is But a Part: <i>JACC: CardioOncology</i> State-of-the-Art Review.
Hayley T Dillon; Stephen J Foulkes; Alan H Baik; Jessica M Scott; Rhian M Touyz; Joerg Herrmann; Mark J Haykowsky; André La Gerche; Erin J Howden
JACC. CARDIOONCOLOGY - 01 Aug 2024
The landscape of cancer therapeutics is continually evolving, with successes in improved survivorship and reduced disease progression for many patients with cancer. Improved cancer outcomes expose competing comorbidities, some of which may be exacerbated by cancer therapies. The leading cause of disability and death for many early-stage cancers is cardiovascular disease (CVD), which is often at...
A Broad-Spectrum α-Glucosidase of Glycoside Hydrolase Family 13 from Marinovum sp., a Member of the Roseobacter Clade.
Jinling Li; Janice W-Y Mui; Bruna M da Silva; Douglas E V Pires; David B Ascher; Niccolay Madiedo Soler; Ethan D Goddard-Borger; Spencer J Williams
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY - 01 Sep 2024
Glycoside hydrolases (GHs) are a diverse group of enzymes that catalyze the hydrolysis of glycosidic bonds. The Carbohydrate-Active enZymes (CAZy) classification organizes GHs into families based on sequence data and function, with fewer than 1% of the predicted proteins characterized biochemically. Consideration of genomic context can provide clues to infer possible enzyme activities for prote...
Cardiac-targeted delivery of a novel Drp1 inhibitor for acute cardioprotection.
Jarmon G Lees; David W Greening; David A Rudd; Jonathon Cross; Ayeshah A Rosdah; Xiangfeng Lai; Tsung Wu Lin; Ren Jie Phang; Anne M Kong; Yali Deng; Simon Crawford; Jessica K Holien; Derek J Hausenloy; Hsin-Hui Shen; Shiang Y Lim
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY PLUS - 01 Sep 2024
Dynamin-related protein 1 (Drp1) is a mitochondrial fission protein and a viable target for cardioprotection against myocardial ischaemia-reperfusion injury. Here, we reported a novel Drp1 inhibitor (DRP1i1), delivered using a cardiac-targeted nanoparticle drug delivery system, as a more effective approach for achieving acute cardioprotection. DRP1i1 was encapsulated in cubosome nanoparticles w...
The International Evidence-based Guidelines for the Assessment and Management of Polycystic Ovary Syndrome: An Exemplar of Person-centred Care.
Bharti Kalra; Nitin Kapoor; Atul Dhingra; Sanjay Kalra
TOUCHREVIEWS IN ENDOCRINOLOGY - 01 Oct 2024
In this opinion piece, we appraise the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 from a person-centric perspective. We discuss how the authors balance evidence with empathy and offer excellence in clinical decision-making while ensuring the empowerment of the affected individual. We note how they skilfully use powerful words and p...
Fulminant eosinophilic myocarditis and refractory ventricular arrhythmias requiring mechanical circulatory support: a case report.
Claudia Brick; Angeline Leet; Hui Tay; David M Kaye; Andrew J Taylor
EUROPEAN HEART JOURNAL. CASE REPORTS - 01 Oct 2024
Fulminant eosinophilic myocarditis (EM) is a rare and often fatal condition that may present atypically and be complicated by ventricular arrhythmias. Treatment involves high-dose corticosteroids to suppress eosinophilia, as well as increasing use of mepolizumab, an anti-interleukin-5 antibody with evidence for long-term efficacy and safety. A 38-year-old woman presented to the emergency depart...
Zein nanoencapsulation enhances the antifungal activity of thymol for postharvest decay control in bananas
Dana Punelas-Villanueva; Ronaniel Almeda; Mari Sherlin Chua; Rico Tabor; Mark Louis P Vidallon; Evelyn Rodriguez
EMERGENT MATERIALS - 16 Sep 2024
The current work describes a nanoparticle system-based approach to enhance the antifungal activity of thymol, a ubiquitous natural antifungal phenolic compound, in postharvest control against banana anthracnose. Thymol was encapsulated within the amphiphilic protein zein by high-shear emulsification, yielding highly dispersible thymol-loaded zein nanoparticles with a high encapsulation efficien...
Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors.
Cheng Hwee Soh; RuiDong Xiang; Fumihiko Takeuchi; Thomas H Marwick
JACC. CARDIOONCOLOGY - 01 Oct 2024
The risk for heart failure (HF) is increased among cancer survivors, but predicting individual HF risk is difficult. Polygenic risk scores (PRS) for HF prediction summarize the combined effects of multiple genetic variants specific to the individual. The aim of this study was to compare clinical HF prediction models with PRS in both cancer and noncancer populations. Cancer and HF diagnoses were...
Integrated clinical risk prediction of type 2 diabetes with a multifactorial polygenic risk score.
Scott C Ritchie; Adam S Butterworth; John Danesh; Joshua C Denny; Francis S Collins; Xueling Sim; Angela Wood; Samuel A Lambert; Stephen Kaptoge; Mark I McCarthy; Anubha Mahajan; Lois G Kim; Yu Xu; Yang Liu; Xilin Jiang; Joel T Gibson; Gad Abraham; Carles Foguet; Lisa Pennells; Hasanga D Manikpurage; Yujian Liang; Henry J Taylor; Emanuele Di Angelantonio; Michael Inouye
MEDRXIV : THE PREPRINT SERVER FOR HEALTH SCIENCES - 26 Aug 2024
Combining information from multiple GWASs for a disease and its risk factors has proven a powerful approach for development of polygenic risk scores (PRSs). This may be particularly useful for type 2 diabetes (T2D), a highly polygenic and heterogeneous disease where the additional predictive value of a PRS is unclear. Here, we use a meta-scoring approach to develop a metaPRS for T2D that incorp...
The Reply.
Beatriz Castillo Rodriguez; Eric A Secemsky; Rajesh V Swaminathan; Dmitriy N Feldman; Markus Schlaich; Yuri Battaglia; Edward J Filippone; Chayakrit Krittanawong
THE AMERICAN JOURNAL OF MEDICINE - 01 Nov 2024
Show more...